Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
04:30pm, Thursday, 28'th Jan 2021
AUDUBON, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year
Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays
11:17am, Tuesday, 19'th Jan 2021
Globus Medical's (GMED) recent product launches are seeing tremendous uptake.
Globus Medical (GMED) Gains From Robot Sales Amid Pandemic Blues
09:47am, Friday, 18'th Dec 2020
Globus Medical (GMED) saw a visible rebound in its revenue trend in the third quarter.
Globus Medical: Entry At The Pullback Paid Off, Upside On Entry Today Equally Exciting
12:54am, Thursday, 17'th Dec 2020
Globus Medical: Entry At The Pullback Paid Off, Upside On Entry Today Equally Exciting
Globus Medical Trauma Division Awarded Purchasing Agreement with Premier Inc.
04:30pm, Wednesday, 09'th Dec 2020
AUDUBON, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, one of t
Why Is Globus Medical (GMED) Up 20.5% Since Last Earnings Report?
11:31am, Friday, 27'th Nov 2020
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?
Globus Medical Announces First Surgeries with ExcelsiusGPS® Interbody Solutions
04:30pm, Thursday, 12'th Nov 2020
New ExcelsiusGPS® Interbody Solutions module expands system for planning and navigating the entire interbody fusion procedure New ExcelsiusGPS® Interbody Solutions module expands system for planning
Globus Medical, Inc. (GMED) CEO Dave Demski on Q3 2020 Results - Earnings Call Transcript
08:05pm, Wednesday, 28'th Oct 2020
Globus Medical, Inc. (GMED) CEO Dave Demski on Q3 2020 Results - Earnings Call Transcript
Globus Medical (GMED) Q3 Earnings and Revenues Top Estimates
06:15pm, Wednesday, 28'th Oct 2020
Globus Medical (GMED) delivered earnings and revenue surprises of 58.06% and 9.30%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical Reports Third Quarter 2020 Results
04:15pm, Wednesday, 28'th Oct 2020
AUDUBON, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 3
Honeywell: Detecting And Cleansing The Air Of COVID-19 (NYSE:HON)
12:29pm, Friday, 16'th Oct 2020
There is growing evidence that COVID-19 can spread through the air. This is concerning as society tries to get back to normal and open schools, stores and restaurants.
Alkira Raises $54M Series B for Network Cloud Offering Following Transformative Customer Deployments
12:00am, Tuesday, 13'th Oct 2020
Alkira customer Koch Industries deploys Network Cloud and leads $54M funding with Sequoia Capital, Kleiner Perkins and GV to reinvent networking.
Stryker Has Looked A Little Mortal Lately, And The Stock Has Suffered
10:28am, Tuesday, 01'st Sep 2020
Stryker has continued to beat expectations, but other med-techs have looked more dynamic, and investor enthusiasm seems to have taken a hit.
NuVasive's Valuation Prices In An Excessively Bearish Outlook
08:14am, Thursday, 27'th Aug 2020
NuVasive benefited from improving elective procedure volumes, and revenue beat expectations, but growth lagged rivals like Globus and Medtronic.
PPD: Gains 10% This Month From Q2 Results On 8.16% FCF Margin, But Valuation Remains Behind
03:52pm, Thursday, 13'th Aug 2020
PPD beats the Street by $84.5 million on revenues, but misses EPS by $0.15. FCF Margin of 8.16% of turnover on FCF position of $339 million exiting the second quarter.
